Christine Baeder

Christine Baeder is the President of Apotex USA, responsible for our business in the United States. She is a leading US pharmaceutical executive with more than twenty years of experience in progressively senior roles.

Christine started her career as a chemist, and quickly transitioned to a specialty branded pharmaceutical sales representative at Organon International, a global healthcare company, before moving into supply chain management and marketing management with Sandoz. Over a 16-year period, Christine held progressively senior positions at Teva Pharmaceuticals. From 2018, she served as Senior Vice President and Chief Operating Officer, US Generics and Biosimilars at Teva, and prior to joining Apotex, was responsible for Teva’s global biosimilars business.

Christine continues to serve as a member of the Board of the Association for Accessible Medicines (AAM) and, following service as the Vice Chair in 2022, and Chair of the Board in 2023. She is a vocal supporter and advocate of the generic and biosimilar pharmaceutical industry, frequently speaking about the importance of the legislative, regulatory, and private cooperation of an industry that supports 90% of the medicine dispensed in the United States.

Christine has a BS degree in Biology from Wright State University in Dayton, Ohio and an MBA from Fuqua School of Business at Duke in Durham, North Carolina.